Sublingual Tablets : An Overview

Authors

  • Rohit S. Nikam  Arvind Gavali College of pharmacy. Jaitapur, Dist - Statra,Maharashra, India
  • Smita P Borkar  Arvind Gavali College of pharmacy. Jaitapur, Dist - Statra,Maharashra, India
  • Dr. Prakash D Jadhav  Arvind Gavali College of pharmacy. Jaitapur, Dist - Statra,Maharashra, India
  • Vishal D. Yadav  Arvind Gavali College of pharmacy. Jaitapur, Dist - Statra,Maharashra, India
  • Apurva V Jadhav  Arvind Gavali College of pharmacy. Jaitapur, Dist - Statra,Maharashra, India

DOI:

https://doi.org//10.32628/IJSRST207357

Keywords:

Bioavailability, Sublingual tablets, Sublingual route, Drug delivery, Solid medicament

Abstract

Drug delivery via the oral mucous membrane is considered to be a promising alternative to the oral route. Sublingual route is a useful when rapid onset of action is desired with better patient compliance than oraly ingested tablets. In terms of permeability, the sublingual area of the oral cavity (i.e. the floor of the mou) is more permeable than the buccal (cheek) area, which in turn is more permeable than the palatal (roof of the mouth) area. A rapid onset of pharmacological effect is often desired for some drugs, especially those used in the treatment of acute disorders. Sublingual tablets disintegrate rapidly and the small amount of saliva present is usually sufficient for achieving disintegration of the dosage form coupled with better dissolution and increased bioavailability.

References

  1. Pistiki A, Galani I, Pyleris E, Barbatzas C, Pimentel M, et al. (2014) In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth. Int J Antimicrob Agents 43: 236-241.
  2. Mantry PS, Munsaf S (2010) Rifaximin for the treatment of hepatic encephalopathy. Transplant Proc 42: 4543-4547.
  3. Rivkin A, Gim S (2011) Rifaximin: New Therapeutic Indication and Future Directions. ClinTher 33: 812-827.
  4. Zhang X, Duan J, Li K, Zhou L, Zhai S (2007) Sensitive quantification of rifaximin in human plasma by liquid chromatography–tandem mass spectrometry. J Chromatogr B 850: 348-355.
  5. Valentin T, Leitner E, Rohn A, Zollner-Schwetz I, Hoenigl M, et al. (2011) Rifaximin intake leads to emergence of rifampin-resistant staphylococci. J Infect 62: 34-38.
  6. Birudaraj R, Berner B, Shen S, Li X. Buccal permeation of Buspirone: Mechanistic studies on transport pathways. J Pharm Sci2005 ; 94: 70-78.
  7. Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW. Single dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta estradiol. Obstet Gynecol. 1997; 89:340-345.
  8. Kurosaki Y, Takatori T, Nishimura H, Nakayama T, Kimura T. Regional variation in oral mucosal drug absorption permeability and degree of keratinization in hamster oral cavity. Pharm Res 1991;8:1297-1301.
  9. Allen LV. Rapid dissolving technology : an interview with loyd. Allen. International journal of pharmaceutical technology 2003;7:449-450.
  10. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste masking and clinical studies. Crit Rev Ther Drug Carrier system 2004;21:433-476.
  11. Richman MD, Fox D, Shangraw RF. Preparation and stability of glyceryl trinitrate sublingual tablets prepared by direct compression. Journal of pharmaceutical science 1965;54(3):447-451.
  12. Al-Ghananeem AM, Malkawi AH, Crooks PA. Effect of ph on sublingual absorption of oxycodone hydrochloride. AAPS Pharm Sci Tech 2006; 7(1): Article 23.
  13. Rubinstein NH. 2000 Tablets In; Aulton‰, M.E(Ed), Pharmaceutics, the Science of Dosage Form Design Churchill Livingstone, Edinburgh London on Melbourne and New York, Page 305.
  14. Bhati R, Nagrajan RK. A detailed review non oral mucosal drug delivery system. IJPSR 2012; Vol3 (1):659- 681.
  15. Reddy LH. IJPS 2002;0975-1491
  16. Narang N, sharma J. Sublingual mucosa as a route for systemic drug delivery. Int J Pharm PharmSci 2011;3(2): 18-22
  17. Denny PC, Ball WD, Redman RS. Salivary glands: a paradigm fordiversity of gland development. Crit Rev Oral Biot Med1997; 8(1): 51-75.
  18. Bind AK, Gnanarajan G and kothiyal P.A review: sublingual route for systemic drug delivery. Int. J. Drug res. Tech2013; 3 (2):31-36.
  19. Katz, M and Barr, M (1955), “A study of sublingual absorption I. Several factors influencing the rate of adsorption”, J Am Pharm AssocAm Pharm Assoc, 44(7), 419?423.
  20. Allen, LV (2003), “Rapid?dissolve technology: an interview”, Int J Pharm Technol, 7,449?450.
  21. Fu, Y; Yang, S; Jeong, SH;Kimura, S and Park, K(2004), “Orally fast disintegrating tablets: developments, technologies, taste making and clinical studies”, Crit Rev Ther Drug Carrier Syst, 21,433?476.
  22. The European Agency for the Evaluation of Medicinal Products EMA (2001) Committee for Proprietary Medicinal Products (CPMP) Note for guidance on the investigation of Bioavailability and Bioequivalence, London.
  23. Perry R (2010) Perspectives on the bioequivalence and therapeutic equivalence of generic formulations: An overview of the landscape. ClinTher 32: 1796- 1797.
  24. WHO (2006) Technical Report series, Fortieth Report, Geneva.
  25. Patel P et al. Sublingual route for the systemic delivery of ondansetron. Int. J. Drug Dev& Res 2011; 3 (4): 36- 44.
  26. Prajapati B, Kaur S, RoopiniSA.Formulation and evaluation of mouth dissolving sublingual tablets of cimetidine to treat abdominal cramps. International Journal of Pharmaceutical Science Invention2014; 3 (9):41-46.
  27. Godbole AM et al.Formulation and in-vitro evaluation of sublingual tablets of ondansetron hydrochloride using coprocessed excipients, Indian Journal of Pharmaceutical Education and Research 2014;48: 7-17.
  28. SheuMT et al. Rapid-onset sildenafil sublingual drug delivery systems: in vitro evaluation and in vivo pharmacokinetic studies in rabbits. Journal of Pharmaceutical Sciences 2016; 105: 2774-2781.
  29. Rao GK et al. Formulation and evaluation of sublingual tablets of oxazepam. International Journal of Universal Pharmacy and Bio Sciences 2013; 2(6):35-46.
  30. Satyam ZC, Parmeshwar K and Pallavi D. Formulation and evaluation of mucoadhesive sublingual tablet of rosuvastatin calcium. Journal of Chemical And Pharmaceutical Research 2014; 6(8):375-383.
  31. Madhagi Wet al. Formulation and Evaluation of New Glimepiride Sublingual Tablets. Journal of Pharmaceutics 2017; 1-5.
  32. Yadav S, Garg S, Pareek AK, Kumar P and Kumar M. Formulation and optimization of sublingual tablet of ramipril.Journal Of Chemical And Pharmaceutical Research 2015; 7(8): 1077-1086.
  33. Akbar M, Panda N, Reddy AV.Formulation and evaluation of doxofylline sublingual tablets using sodium starch glycolate and crosscarmellose sodium as superdisintegrant. Int. j. pharm. res. allied sci 2015; 4(2):90-100.
  34. Grover I, Aggarwal G. Formulation and evaluation of lisinopril. J SciInd Res 2012; 71:413-417.
  35. Bhupinder B, SaritaJ.Formulation and evaluation of fast dissolving sublingual films of rizatriptan benzoate. Int. j. drug dev. res. 2012; 4(1): 133-143.
  36. Aparna B, Kumar B, Gnanaprakash K, Gobinath M, Y Ramesh. Development and evaluation of sublingual tablets of aripiprazole. International Journal of Biopharmaceutics2014; 5(4): 251-257.
  37. Sheeba FR, Giles D, Rameshwari S, AnandhiJ.Formulation and evaluation of nifedipine sublingual tablets. Asian J Pharm Clin Res 2009; 2(3): 44-48.
  38. Raju KN, Velmurugan S, Deepika B, Vinushitha S. Formulation and invitroevaluation of buccal tablets of metoprolol tartrate. Int J Pharm PharmSci 2011;3(2): 239-246.
  39. Bredenberg S et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Pharm Sci 2003; 20:327–334

International Journal of Scientific Research in Science and Technology

Downloads

Published

2020-06-30

Issue

Volume 7, Issue 3, May-June-2020

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Rohit S. Nikam, Smita P Borkar, Dr. Prakash D Jadhav, Vishal D. Yadav, Apurva V Jadhav, " Sublingual Tablets : An Overview, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 7, Issue 3, pp.333-339, May-June-2020. Available at doi : https://doi.org/10.32628/IJSRST207357